Product Information
RANOLAZINE ER 1,000 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2787 per EA under NDC 68462032060. Its NADAC has been published 363 times since Sep 11, 2019.
FDA first approved this application on Jul 5, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032060
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA211082FDA Approved
7/5/2019
TE Code
AB
On Market Since
7/5/2019
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 1,000 MG TABLET has been published 363 times since Sep 11, 2019, and over the history we have for it it has declined 75.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2787 per EA |
|---|---|
| All-time high | $1.1472 (Oct 16, 2019) |
| All-time low | $0.2725 (Apr 22, 2026) |
| 52-week high | $0.3159 |
| 52-week low | $0.2725 |
| Median price | $0.3614 |
| Average price | $0.4924 |
| Largest weekly change | -21.2% (Mar 23, 2022) |
| Weeks tracked | 363 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 1,000 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2787 per EA (NDC 68462032060), effective Aug 19, 2026.
How has the price of RANOLAZINE ER 1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 1,000 MG TABLET has declined 75.7%. It has been tracked across 363 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 1,000 MG TABLET?
Since Sep 11, 2019, the NADAC for RANOLAZINE ER 1,000 MG TABLET has ranged from a low of $0.2725 (Apr 22, 2026) to a high of $1.1472 (Oct 16, 2019), with a median of $0.3614 per EA.
Are there cheaper alternatives to RANOLAZINE ER 1,000 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RANOLAZINE ER 1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RANOLAZINE ER 1,000 MG TABLET?
RANOLAZINE ER 1,000 MG TABLET (NDC 68462032060) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.